Bio-Thera Solutions, Ltd. (SHA:688177)
China · Delayed Price · Currency is CNY 22.62
+1.12 (5.21%)
At close: Mar 6, 2026
Bio-Thera Solutions Market Cap
Bio-Thera Solutions has a market cap or net worth of 9.37 billion as of March 6, 2026. Its market cap has increased by 15.88% in one year.
Market Cap
9.37B
Enterprise Value
9.75B
Revenue
933.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.62
Market Cap Chart
Since February 21, 2020, Bio-Thera Solutions's market cap has decreased from 24.93B to 9.37B, a decrease of -62.43%. That is a compound annual growth rate of -14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.37B | -2.25% |
| Dec 31, 2025 | 9.58B | 19.40% |
| Dec 31, 2024 | 8.02B | -53.01% |
| Dec 29, 2023 | 17.08B | 89.35% |
| Dec 30, 2022 | 9.02B | -15.68% |
| Dec 31, 2021 | 10.70B | -18.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 10.02B |
| Chengdu Easton Biopharmaceuticals | 9.42B |
| Chongqing Genrix Biopharmaceutical | 9.39B |
| Shanghai Medicilon | 8.64B |
| Sino Biological,Inc. | 8.42B |
| Daan Gene | 8.31B |
| Jiangxi Fushine Pharmaceutical | 8.11B |
| Chengdu Kanghua Biological Products | 8.05B |